Going anti-Viral
Going anti-Viral
Going Anti-Viral
Introducing Going anti-Viral, the podcast of the IAS–USA, a professional continuing medical education organization focused on HIV and other viral diseases. I’m Dr Michael Saag, professor emeritus of medicine and infectious diseases at the University of Alabama at Birmingham and volunteer member of the IAS–USA Board of Directors.  Join us as we interview experts in viral medicine about their area of specialty and current developments in the field. Other episodes are drawn from the IAS-USA vast catalogue of panel discussions, Dialogues, and various meetings and conferences.  Going anti-Viral is a podcast series for clinicians, produced by the International Antiviral Society–USA. The IAS–USA is a not-for-profit professional organization committed to improving the treatment, care, and quality of life for people with or at risk for HIV or other viral infections and their complications through balanced education and information. This podcast is intended as a clinical source of information for specialists in this field, but we hope anyone listening will enjoy learning more about the state of modern medicine around viral infections and their consequences.
How HIV Research Drives Breakthroughs for Other Diseases - Dr Andrea Gramatica
In episode 85 of Going anti-Viral, Dr Andrea Gramatica joins host Dr Michael Saag to discuss the work of amfAR and how HIV research drives breakthroughs for other diseases. Dr Gramatica is Vice President of Research at amfAR and an expert in immunology and HIV virology with a research focus on viral persistence and immune modulation. Dr Gramatica is responsible for shaping the strategic direction of amfAR’s research programs, including building upon existing research into HIV and other viral ...
Aug 25
24 min
How USAID Was Dismantled—and What the World Lost - Nicholas Enrich
In episode 84 of Going anti-Viral, Nicholas Enrich joins host Dr Michael Saag to discuss his book Into the Wood Chipper: A Whistleblower's Account of How the Trump Administration Shredded USAID. Mr Enrich is a former civil servant who worked at the United States Agency for International Development (USAID) under 4 administrations. He served as the Bureau of Global Health director of policy, programs, and planning until January 2025, when he was designated as the USAID acting assistant adminis...
Aug 14
44 min
New Guidelines for Statin Use in People with HIV – REPRIEVE Trial Updates - Dr Steven Grinspoon
In episode 83 of Going anti-Viral, Dr Steven Grinspoon joins host Dr Michael Saag to provide an update on guidelines for statin use in people with HIV based on results from the REPRIEVE trial. Dr Grinspoon is a Professor of Medicine at Harvard Medical School and a clinician in the Neuroendocrine and Pituitary Tumor Clinical Center and faculty member at the Massachusetts General Hospital. He is a clinical researcher who studies hypothalamic control of body weight and fat distribution in obesit...
Jul 28
28 min
Tracking Ebola — Outbreak Status and the International Response - Dr Tyler Evans
In episode 82 of Going anti-Viral, Dr Tyler Evans joins host Dr Michael Saag to discuss the Ebola outbreak in the Democratic Republic of the Congo and Uganda and the global response. Dr Evans is an infectious diseases and addiction medicine physician and CEO of Wellness Equity Alliance, a national organization advancing health equity in the US and globally. He is also an associate professor of population and public health sciences at the University of Southern California Keck School of Medici...
Jul 14
31 min
Progress in HIV Cure Research: Can a Single Shot Deliver a Functional Cure? - Dr Steven Deeks
In episode 81 of Going anti-Viral, Dr Steven Deeks joins host Dr Michael Saag to discuss recent research demonstrating the promise of a single shot in a functional cure of HIV. Dr Deeks is a Professor of Medicine in Residence at the University of California, San Francisco (UCSF) and is a faculty member in the Division of HIV, Infectious Diseases and Global Medicine at Zuckerberg San Francisco General Hospital. He is an internationally recognized expert on HIV pathogenesis and treatment and is...
Jun 30
31 min
TMVII: Understanding the Emergence of Trichophyton mentagrophytes Genotype VII – Dr Jason Zucker
In episode 80 of Going anti-Viral, Dr Jason Zucker joins host Dr Michael Saag to provide an update on the Trichophyton mentagrophytes genotype VII (TMVII) infection. Dr Zucker is an Assistant Professor of Medicine at Columbia University and Assistant Medical Director of the New York City STD Prevention Training Center. Dr Zucker is an experienced HIV, HIV prevention, and sexual health care provider providing status-neutral care to patients of all ages in New York. His research focuses on the ...
Jun 16
19 min
Special Episode - Latest Update on Emerging Infections and Health Threats
In episode 79 of Going anti-Viral, we represent a panel discussion from June 9, 2026, as part of the IAS–USA Dialogue series Emerging Infections and Health Threats. This Dialogue is a must listen as our distinguished panel of infectious disease experts dives deep into some of the most pressing public health challenges facing the world today. Moderated by Carlos del Rio, MD, a Distinguished Professor of Medicine in the Division of Infectious Diseases at Emory University School of Medicine, thi...
Jun 12
1 hr 2 min
From Data to Guidance: The Process Behind Clinical Guidelines – Dr Rajesh Gandhi
In episode 78 of Going anti-Viral, Dr Rajesh T. Gandhi joins host Dr Michael Saag to discuss the process of guidelines development. Dr Gandhi is a Professor of Medicine at Harvard Medical School and Principal Investigator and Co-Director of the Harvard University Center for AIDS Research (CFAR). Dr Gandhi is the Vice-Chair of the ACTG, Vice-Chair of the Infectious Diseases Society of America COVID-19 Treatment Guidelines Panel, Chair of the International Antiviral Society-USA Panel on Antiret...
Jun 2
30 min
Management of Hepatitis B Virus Infection and Vaccination – Dr Debika Bhattacharya
In episode 77 of Going anti-Viral, Dr Debika Bhattacharya joins host Dr Michael Saag to discuss the management of hepatitis B virus (HBV) infection and vaccination. Dr Bhattacharya is a Clinical Professor at the University of California Los Angeles (UCLA) David Geffen School of Medicine and specializes in the management of HIV and HIV/viral hepatitis coinfection and sees patients with viral hepatitis and HIV/viral hepatitis coinfection at UCLA and its affiliated clinics. Her research involves...
May 19
32 min
The Impact of Long-acting Injectable HIV Treatments on Public Health – Dr Kelly Gebo
In episode 76 of Going anti-Viral, Dr Kelly Gebo joins host Dr Michael Saag to discuss the impact of long-acting injectable HIV treatments on public health. Dr Gebo is Dean of the Milken Institute School of Public Health at the George Washington University. An infectious disease physician-scientist, educator, and accomplished academic leader, Dr Gebo’s work focuses on health equity, access to care, and outcomes for people affected by infectious diseases such as HIV, COVID-19, and Mpox. Dr Geb...
May 5
26 min
Load more